{"id":6925,"date":"2026-05-04T13:48:54","date_gmt":"2026-05-04T08:18:54","guid":{"rendered":"https:\/\/nervnow.com\/?p=6925"},"modified":"2026-05-04T14:01:42","modified_gmt":"2026-05-04T08:31:42","slug":"linkerbot-eyes-6b-valuation-double-its-latest-3b-mark","status":"publish","type":"post","link":"https:\/\/nervnow.com\/ro\/linkerbot-eyes-6b-valuation-double-its-latest-3b-mark\/","title":{"rendered":"Linkerbot Eyes $6B Valuation, Double Its Latest $3B Mark"},"content":{"rendered":"<p><em><strong>Backed by Ant Group and HongShan, Linkerbot plans to double monthly output to 10,000 robotic hands as Chinese factories increasingly skip full humanoids in favor of modular dexterous components.<\/strong><\/em><\/p>\n\n\n\n<p>Linkerbot, the Beijing-based startup behind some of the world&#8217;s most dexterous robotic hands, could be heading for a $6 billion valuation in its next funding round, double the $3 billion mark it hit just last week, according to a Reuters report.<\/p>\n\n\n\n<p>The two-year-old unicorn has not disclosed when the round will launch, or whether the reported $6 billion target will come through a private investment round or an initial public offering.<\/p>\n\n\n\n<p>Linkerbot wrapped what it called a &#8220;Series B+&#8221; round last week, valuing it at $3 billion. Early backers of the company include Alibaba&#8217;s Ant Group and HongShan Group, the China-focused firm spun out of Sequoia. The latest round drew participation from the state-backed Zhongguancun Science Park Fund, Bank of China Asset Management and Fosun Capital.<\/p>\n\n\n\n<p>The company holds more than 80% of the global market for high-degree-of-freedom (DoF) robotic hands, the dexterous end-effectors that allow humanoid and industrial robots to manipulate objects with near-human precision. CEO Alex Zhou told Reuters that Linkerbot plans to scale production &#8220;soon&#8221; to 10,000 units a month, up from roughly 5,000 today.<\/p>\n\n\n\n<p><strong>ALSO READ: <a href=\"https:\/\/nervnow.com\/ro\/alp-bio-raises-e1-9m-for-ai-drug-discovery-platform\/\" target=\"_blank\" rel=\"noopener\" title=\"\">ALP Bio Raises \u20ac1.9M for AI Drug Discovery Platform<\/a><\/strong><\/p>\n\n\n\n<p>Linkerbot&#8217;s hands can already turn screws at speed, grasp soft and deformable objects, thread a needle and handle high-precision manufacturing tasks. Its base O6 lightweight model weighs just 370 grams but can carry a 50 kg load, a strength-to-weight ratio Zhou said is a critical advantage in industrial applications where miniaturization matters.<\/p>\n\n\n\n<p>The company makes key components, joint modules, motors and reducers, in-house, and uses specialized self-lubricating, corrosion-resistant polymers. It supplies several of China&#8217;s leading humanoid robot makers, along with foreign industrial customers that have not been disclosed due to NDAs. Its hands are also used by research institutes and global universities.<\/p>\n\n\n\n<p>Linkerbot now has more than 400 employees and five factories across Beijing and Shenzhen. It is also building intelligent production lines where robotic hands assemble other robotic hands.<\/p>\n\n\n\n<p>The bigger picture is one of cost arbitrage. Industrial humanoid robots from leading Chinese players like Unitree, AgiBot and UBTech sell for $100,000 to $150,000 per unit, a price point analysts say has slowed factory adoption. Zhou argued that for most factory work, full humanoids are overkill: &#8220;Chinese factory owners are extremely pragmatic. They&#8217;ve realized that for most factory work, two arms and a pair of dexterous hands are enough.&#8221; Many of Linkerbot&#8217;s customers, he said, simply mount its hands onto existing robotic arms, getting most of the value of a humanoid at a fraction of the cost.<\/p>\n\n\n\n<p>If Linkerbot lands the $6 billion mark, it will signal that investors are increasingly betting not on full humanoid robots, but on the modular components, particularly the hands, that make those robots actually useful.<\/p>\n\n\n\n<p class=\"has-palette-color-8-color has-palette-color-9-background-color has-text-color has-background has-link-color wp-elements-ea4ed2697a88c3a65a4cd9c0f64a0548\"><strong>MORE ON AI FUNDINGS &amp; STARTUPS<\/strong><br><a href=\"https:\/\/nervnow.com\/ro\/planet-labs-launches-3-ai-powered-pelican-satellites-into-orbit\/\" target=\"_blank\" rel=\"noopener\" title=\"\">Planet Labs Launches 3 AI-Powered Pelican Satellites Into Orbit<\/a><br><a href=\"https:\/\/nervnow.com\/ro\/nebius-to-acquire-eigen-ai-for-643m-eyes-ai-infrastructure-growth\/\" target=\"_blank\" rel=\"noopener\" title=\"\">Nebius to Acquire Eigen AI for $643M, Eyes AI Infrastructure Growth<\/a><br><a href=\"https:\/\/nervnow.com\/ro\/avoca-raises-125m-series-b-hits-unicorn-status\/\" target=\"_blank\" rel=\"noopener\" title=\"\">Avoca Raises $125M Series B, Hits Unicorn Status<\/a><br><a href=\"https:\/\/nervnow.com\/ro\/portkey-heads-to-palo-alto-networks-in-latest-india-to-global-ai-exit\/\" target=\"_blank\" rel=\"noopener\" title=\"\">Portkey Heads to Palo Alto Networks in Latest India-to-Global AI Exit<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>The two-year-old Beijing unicorn, Linkerbot, backed by Ant Group and Sequoia spin-off HongShan, controls more than 80% of the global market for robotic hands.<\/p>","protected":false},"author":2,"featured_media":6926,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_gspb_post_css":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[101,94],"tags":[196,84],"class_list":["post-6925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-funding-startups","category-news","tag-global","tag-just-in"],"blocksy_meta":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/6925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/comments?post=6925"}],"version-history":[{"count":1,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/6925\/revisions"}],"predecessor-version":[{"id":6927,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/posts\/6925\/revisions\/6927"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/media\/6926"}],"wp:attachment":[{"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/media?parent=6925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/categories?post=6925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nervnow.com\/ro\/wp-json\/wp\/v2\/tags?post=6925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}